Kidney function and cognitive and physical decline in older women

老年女性的肾功能以及认知和身体衰退

基本信息

  • 批准号:
    7910495
  • 负责人:
  • 金额:
    $ 34.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-04-01 至 2012-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Progressive cognitive and physical function decline in the aging population in the United States requires a substantial allocation of healthcare resources. Aging is also associated with increased prevalence of chronic kidney disease. Advanced kidney failure is an important etiology of cognitive and physical dysfunction, likely mediated through vascular disease, abnormal mineral metabolism, and neuromuscular degeneration, but sparse data are available concerning the role of mild and moderate kidney failure. We hypothesize that mild and moderate chronic kidney disease will be independently associated with cognitive and physical decline in older adults. This prospective study will include 3700 community-dwelling women participating in the Nurses' Health Study who are aged 70 and older, have stored plasma from 1989 and 2000, stored urine from 2000, and who have undergone repeated cognitive function testing every two years. Physical function is assessed every four years by the physical component score of the Short Form-36, walking pace, and frequency of falls as reported on the questionnaires. Our measurements of cognitive and physical functioning have been validated as significant predictors of morbidity and mortality in population-based studies of older adults. We will assay plasma for creatinine, which will allow us to estimate GFR, and urine for microalbuminuria. A growth curve approach to multivariable modeling to test for associations between kidney dysfunction and subsequent 1) cognitive or 2) physical function decline will allow us to take advantage of multiple repeated measures of these outcomes obtained between 2000 and 2008. Specific aims of this proposal include evaluating how 1) baseline eGFR in 2000, 2) >25% eGFR decline between 1989 and 2000 (over 11 years), and 3) presence of microalbuminuria are related to cognitive and physical decline between 2000 and 2008 (over 8 years). We will also investigate whether inflammatory biomarkers, namely C- reactive protein, fibrinogen, and tumor necrosis factor a receptor-2, may potentially mediate associations between kidney dysfunction and functional decline. We will have >80% power for our aims. Completed and on-going work in this established cohort make this project extremely cost-effective. From a public health perspective, recognition of these associations may result in improving clinical care for the geriatric population through medical management strategies that slow progression of early and moderate kidney disease, cognitive impairment, and physical function decline. Thus, findings from this longitudinal, prospective study of a large cohort of older women will meaningfully improve the quality of life and longevity of community-dwelling older citizens.
描述(由申请人提供):美国老龄化人口的渐进认知和身体机能下降需要大量的医疗资源分配。衰老也与慢性肾脏疾病的患病率增加有关。晚期肾衰竭是认知和物理功能障碍的重要病因,可能是通过血管疾病,异常矿物质代谢和神经肌肉变性介导的,但是关于轻度和中等肾脏衰竭的作用稀疏数据。我们假设轻度和中度的慢性肾脏疾病将与老年人的认知和身体下降独立相关。这项前瞻性研究将包括参加70岁及70岁以上护士健康研究的3700名社区居民妇女,从1989年和2000年开始存储血浆,从2000年储存了尿液,并且每两年进行一次重复的认知功能。每四年的身体成分得分每四年评估,如问卷所示,较短的表格-36,步行步伐和跌倒频率。我们对认知和身体功能的测量已被证实为对老年人的基于人群研究的发病率和死亡率的重要预测指标。我们将分析肌酐的等离子体,这将使我们能够估计GFR,并为微藻尿症尿液。 A growth curve approach to multivariable modeling to test for associations between kidney dysfunction and subsequent 1) cognitive or 2) physical function decline will allow us to take advantage of multiple repeated measures of these outcomes obtained between 2000 and 2008. Specific aims of this proposal include evaluating how 1) baseline eGFR in 2000, 2) >25% eGFR decline between 1989 and 2000 (over 11 years), and 3) presence of微量白蛋白尿与2000年至2008年(超过8年)之间的认知和身体下降有关。我们还将研究炎性生物标志物,即C-反应性蛋白,纤维蛋白原和肿瘤坏死因子A受体-2是否可能介导肾功能障碍与功能下降之间的关联。我们的目标将拥有> 80%的功率。在这个已建立的队列中完成和正在进行的工作使该项目变得极具成本效益。从公共卫生的角度来看,对这些关联的认识可能会通过医疗管理策略改善老年人群的临床护理,从而缓慢早期和中度肾脏疾病,认知障碍以及身体机能下降。因此,对大量老年妇女的纵向,前瞻性研究的结果将有意义地改善社区居住老年人的生活质量和寿命。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JULIE LIN其他文献

JULIE LIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JULIE LIN', 18)}}的其他基金

Kidney function and cognitive and physical decline in older women
老年女性的肾功能以及认知和身体衰退
  • 批准号:
    8056516
  • 财政年份:
    2008
  • 资助金额:
    $ 34.91万
  • 项目类别:
Kidney function and cognitive and physical decline in older women
老年女性的肾功能以及认知和身体衰退
  • 批准号:
    7581040
  • 财政年份:
    2008
  • 资助金额:
    $ 34.91万
  • 项目类别:
Biomarkers in the progression of nephropathy in type 2DM
2 型糖尿病肾病进展中的生物标志物
  • 批准号:
    7478355
  • 财政年份:
    2007
  • 资助金额:
    $ 34.91万
  • 项目类别:
Biomarkers in the progression of nephropathy in type 2DM
2 型糖尿病肾病进展中的生物标志物
  • 批准号:
    7294451
  • 财政年份:
    2007
  • 资助金额:
    $ 34.91万
  • 项目类别:
Predictors of Nephropathy in Type 2 Diabetes
2 型糖尿病肾病的预测因素
  • 批准号:
    6820676
  • 财政年份:
    2004
  • 资助金额:
    $ 34.91万
  • 项目类别:
Predictors of Nephropathy in Type 2 Diabetes
2 型糖尿病肾病的预测因素
  • 批准号:
    7231710
  • 财政年份:
    2004
  • 资助金额:
    $ 34.91万
  • 项目类别:
Predictors of Nephropathy in Type 2 Diabetes
2 型糖尿病肾病的预测因子
  • 批准号:
    7459007
  • 财政年份:
    2004
  • 资助金额:
    $ 34.91万
  • 项目类别:
Predictors of Nephropathy in Type 2 Diabetes
2 型糖尿病肾病的预测因素
  • 批准号:
    7076162
  • 财政年份:
    2004
  • 资助金额:
    $ 34.91万
  • 项目类别:
Predictors of Nephropathy in Type 2 Diabetes
2 型糖尿病肾病的预测因素
  • 批准号:
    6942960
  • 财政年份:
    2004
  • 资助金额:
    $ 34.91万
  • 项目类别:

相似国自然基金

基于前瞻性糖尿病队列筛选与验证早于白蛋白尿/肾功能下降的糖尿病肾病尿液蛋白诊断生物标志物
  • 批准号:
    81900665
  • 批准年份:
    2019
  • 资助金额:
    19.0 万元
  • 项目类别:
    青年科学基金项目
从Rac1-盐皮质激素受体激活途径探讨黄芪菟箭合剂对糖尿病肾病足细胞的保护机制
  • 批准号:
    81873291
  • 批准年份:
    2018
  • 资助金额:
    59.0 万元
  • 项目类别:
    面上项目
巨噬细胞Mincle受体活化在蛋白尿致肾小管间质炎症中的作用及机制研究
  • 批准号:
    31671194
  • 批准年份:
    2016
  • 资助金额:
    61.0 万元
  • 项目类别:
    面上项目
血管生长素2调控足细胞穿胞在糖尿病肾病早期白蛋白尿中的作用及其机制
  • 批准号:
    81570657
  • 批准年份:
    2015
  • 资助金额:
    57.0 万元
  • 项目类别:
    面上项目
Calpain/Calpastatin基因在原发性高血压微量白蛋白尿发生中作用的遗传学前瞻性研究及功能分析
  • 批准号:
    81000037
  • 批准年份:
    2010
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
NAD 增强治疗糖尿病肾病:一项随机对照试验
  • 批准号:
    10430705
  • 财政年份:
    2022
  • 资助金额:
    $ 34.91万
  • 项目类别:
NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
NAD 增强治疗糖尿病肾病:一项随机对照试验
  • 批准号:
    10668324
  • 财政年份:
    2022
  • 资助金额:
    $ 34.91万
  • 项目类别:
Molecular pathology and therapeutics of insulin signaling impairment and Abeta in Alzheimer's disease
阿尔茨海默病中胰岛素信号损伤和 Abeta 的分子病理学和治疗
  • 批准号:
    20K07826
  • 财政年份:
    2020
  • 资助金额:
    $ 34.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Beyond the Glomerulus: Kidney Tubule Dysfunction and Cognitive Impairments in the Elderly
肾小球之外:老年人的肾小管功能障碍和认知障碍
  • 批准号:
    10261422
  • 财政年份:
    2020
  • 资助金额:
    $ 34.91万
  • 项目类别:
Impairment of insulin signaling in Alzheimer's disease and combined therapy with apomorphine and insulin
阿尔茨海默病中胰岛素信号传导受损以及阿扑吗啡和胰岛素联合治疗
  • 批准号:
    17K09302
  • 财政年份:
    2017
  • 资助金额:
    $ 34.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了